nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—SHH—pancreatic cancer	0.0415	0.12	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—PTHLH—pancreatic cancer	0.0394	0.114	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—PTCH1—pancreatic cancer	0.0394	0.114	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—SOD2—pancreatic cancer	0.0136	0.0394	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—APOE—pancreatic cancer	0.0133	0.0384	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—APOE—pancreatic cancer	0.0112	0.0323	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—PIK3CA—pancreatic cancer	0.0089	0.0257	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—AKT1—pancreatic cancer	0.00727	0.021	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—APOE—pancreatic cancer	0.00679	0.0196	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—TNF—pancreatic cancer	0.00517	0.0149	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GDI1—pancreatic cancer	0.00358	0.0103	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GDI2—pancreatic cancer	0.00358	0.0103	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00345	0.00998	CbGpPWpGaD
Gentamicin—LRP2—Disease—PRSS1—pancreatic cancer	0.0031	0.00895	CbGpPWpGaD
Gentamicin—LRP2—Disease—ZNRF3—pancreatic cancer	0.0031	0.00895	CbGpPWpGaD
Gentamicin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.00287	0.0083	CbGpPWpGaD
Gentamicin—LRP2—Disease—DTX1—pancreatic cancer	0.0028	0.00809	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Sunitinib—pancreatic cancer	0.00279	0.00426	CcSEcCtD
Gentamicin—Eosinophilia—Fluorouracil—pancreatic cancer	0.00273	0.00418	CcSEcCtD
Gentamicin—Phlebitis—Docetaxel—pancreatic cancer	0.00267	0.00409	CcSEcCtD
Gentamicin—Anaemia—Tamoxifen—pancreatic cancer	0.00263	0.00402	CcSEcCtD
Gentamicin—Injection site pain—Epirubicin—pancreatic cancer	0.00262	0.00401	CcSEcCtD
Gentamicin—Weight decreased—Irinotecan—pancreatic cancer	0.00261	0.00399	CcSEcCtD
Gentamicin—LRP2—Metabolism—PRSS1—pancreatic cancer	0.00259	0.00749	CbGpPWpGaD
Gentamicin—Deafness—Docetaxel—pancreatic cancer	0.00258	0.00394	CcSEcCtD
Gentamicin—Leukopenia—Tamoxifen—pancreatic cancer	0.00255	0.00389	CcSEcCtD
Gentamicin—Stomatitis—Irinotecan—pancreatic cancer	0.0025	0.00383	CcSEcCtD
Gentamicin—Alopecia—Sunitinib—pancreatic cancer	0.00247	0.00378	CcSEcCtD
Gentamicin—Hypertension—Tamoxifen—pancreatic cancer	0.00246	0.00376	CcSEcCtD
Gentamicin—Extravasation—Epirubicin—pancreatic cancer	0.00245	0.00375	CcSEcCtD
Gentamicin—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.00245	0.00375	CcSEcCtD
Gentamicin—Stomatitis—Gemcitabine—pancreatic cancer	0.00244	0.00373	CcSEcCtD
Gentamicin—Erythema—Sunitinib—pancreatic cancer	0.00244	0.00373	CcSEcCtD
Gentamicin—Visual disturbance—Docetaxel—pancreatic cancer	0.00243	0.00372	CcSEcCtD
Gentamicin—Injection site pain—Doxorubicin—pancreatic cancer	0.00243	0.00371	CcSEcCtD
Gentamicin—Arthralgia—Tamoxifen—pancreatic cancer	0.00242	0.0037	CcSEcCtD
Gentamicin—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.00241	0.00369	CcSEcCtD
Gentamicin—Stomatitis—Fluorouracil—pancreatic cancer	0.0024	0.00367	CcSEcCtD
Gentamicin—Arthralgia—Erlotinib—pancreatic cancer	0.0024	0.00366	CcSEcCtD
Gentamicin—Lethargy—Docetaxel—pancreatic cancer	0.00235	0.0036	CcSEcCtD
Gentamicin—LRP2—Disease—DTX4—pancreatic cancer	0.00235	0.00678	CbGpPWpGaD
Gentamicin—Hypocalcaemia—Epirubicin—pancreatic cancer	0.00234	0.00358	CcSEcCtD
Gentamicin—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00233	0.00357	CcSEcCtD
Gentamicin—Oliguria—Epirubicin—pancreatic cancer	0.00232	0.00355	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PRLHR—pancreatic cancer	0.00231	0.00666	CbGpPWpGaD
Gentamicin—Agranulocytosis—Fluorouracil—pancreatic cancer	0.0023	0.00351	CcSEcCtD
Gentamicin—LRP2—Disease—PPP2R5B—pancreatic cancer	0.00228	0.0066	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00227	0.00348	CcSEcCtD
Gentamicin—Extravasation—Doxorubicin—pancreatic cancer	0.00227	0.00347	CcSEcCtD
Gentamicin—Anaemia—Sunitinib—pancreatic cancer	0.00225	0.00344	CcSEcCtD
Gentamicin—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00225	0.00344	CcSEcCtD
Gentamicin—LRP2—Metabolism—ARG2—pancreatic cancer	0.00225	0.0065	CbGpPWpGaD
Gentamicin—Visual impairment—Irinotecan—pancreatic cancer	0.00222	0.0034	CcSEcCtD
Gentamicin—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.0022	0.00336	CcSEcCtD
Gentamicin—LRP2—Disease—HEY2—pancreatic cancer	0.0022	0.00635	CbGpPWpGaD
Gentamicin—Leukopenia—Sunitinib—pancreatic cancer	0.00218	0.00334	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ZNRF3—pancreatic cancer	0.00217	0.00626	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ACVR1B—pancreatic cancer	0.00217	0.00626	CbGpPWpGaD
Gentamicin—Hypocalcaemia—Doxorubicin—pancreatic cancer	0.00216	0.00331	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00215	0.00622	CbGpPWpGaD
Gentamicin—Oliguria—Doxorubicin—pancreatic cancer	0.00215	0.00329	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.00212	0.00323	CcSEcCtD
Gentamicin—Convulsion—Sunitinib—pancreatic cancer	0.00211	0.00323	CcSEcCtD
Gentamicin—Hypertension—Sunitinib—pancreatic cancer	0.0021	0.00322	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00209	0.0032	CcSEcCtD
Gentamicin—Paraesthesia—Tamoxifen—pancreatic cancer	0.00208	0.00319	CcSEcCtD
Gentamicin—Salivary hypersecretion—Epirubicin—pancreatic cancer	0.00208	0.00318	CcSEcCtD
Gentamicin—Arthralgia—Sunitinib—pancreatic cancer	0.00207	0.00317	CcSEcCtD
Gentamicin—Alopecia—Irinotecan—pancreatic cancer	0.00204	0.00312	CcSEcCtD
Gentamicin—LRP2—Disease—HEY1—pancreatic cancer	0.00203	0.00588	CbGpPWpGaD
Gentamicin—Decreased appetite—Tamoxifen—pancreatic cancer	0.00202	0.00309	CcSEcCtD
Gentamicin—Decreased appetite—Erlotinib—pancreatic cancer	0.002	0.00305	CcSEcCtD
Gentamicin—Alopecia—Gemcitabine—pancreatic cancer	0.00198	0.00303	CcSEcCtD
Gentamicin—LRP2—Metabolism—TYMP—pancreatic cancer	0.00196	0.00568	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SSTR3—pancreatic cancer	0.00196	0.00567	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—DTX1—pancreatic cancer	0.00196	0.00567	CbGpPWpGaD
Gentamicin—Erythema—Gemcitabine—pancreatic cancer	0.00196	0.00299	CcSEcCtD
Gentamicin—Alopecia—Fluorouracil—pancreatic cancer	0.00195	0.00298	CcSEcCtD
Gentamicin—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00195	0.00298	CcSEcCtD
Gentamicin—Salivary hypersecretion—Doxorubicin—pancreatic cancer	0.00192	0.00294	CcSEcCtD
Gentamicin—Erythema—Fluorouracil—pancreatic cancer	0.00192	0.00294	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SSTR1—pancreatic cancer	0.00188	0.00543	CbGpPWpGaD
Gentamicin—Anaemia—Irinotecan—pancreatic cancer	0.00186	0.00284	CcSEcCtD
Gentamicin—Urticaria—Tamoxifen—pancreatic cancer	0.00184	0.00282	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PPY—pancreatic cancer	0.00184	0.00533	CbGpPWpGaD
Gentamicin—Body temperature increased—Erlotinib—pancreatic cancer	0.00182	0.00278	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00181	0.00277	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SSTR2—pancreatic cancer	0.00181	0.00523	CbGpPWpGaD
Gentamicin—Anaemia—Gemcitabine—pancreatic cancer	0.00181	0.00276	CcSEcCtD
Gentamicin—LRP2—Disease—JAG2—pancreatic cancer	0.0018	0.00521	CbGpPWpGaD
Gentamicin—Phlebitis—Epirubicin—pancreatic cancer	0.0018	0.00276	CcSEcCtD
Gentamicin—Vertigo—Irinotecan—pancreatic cancer	0.0018	0.00276	CcSEcCtD
Gentamicin—Weight decreased—Docetaxel—pancreatic cancer	0.0018	0.00275	CcSEcCtD
Gentamicin—Leukopenia—Irinotecan—pancreatic cancer	0.0018	0.00275	CcSEcCtD
Gentamicin—Paraesthesia—Sunitinib—pancreatic cancer	0.00179	0.00273	CcSEcCtD
Gentamicin—LRP2—Disease—MEN1—pancreatic cancer	0.00178	0.00514	CbGpPWpGaD
Gentamicin—Anaemia—Fluorouracil—pancreatic cancer	0.00178	0.00272	CcSEcCtD
Gentamicin—LRP2—Disease—SLC2A2—pancreatic cancer	0.00177	0.0051	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00175	0.00507	CbGpPWpGaD
Gentamicin—Leukopenia—Gemcitabine—pancreatic cancer	0.00175	0.00268	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCKBR—pancreatic cancer	0.00175	0.00505	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.00174	0.00266	CcSEcCtD
Gentamicin—Vascular purpura—Epirubicin—pancreatic cancer	0.00174	0.00266	CcSEcCtD
Gentamicin—Hypertension—Irinotecan—pancreatic cancer	0.00173	0.00265	CcSEcCtD
Gentamicin—Stomatitis—Docetaxel—pancreatic cancer	0.00173	0.00265	CcSEcCtD
Gentamicin—Decreased appetite—Sunitinib—pancreatic cancer	0.00173	0.00264	CcSEcCtD
Gentamicin—Leukopenia—Fluorouracil—pancreatic cancer	0.00172	0.00263	CcSEcCtD
Gentamicin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00171	0.00262	CcSEcCtD
Gentamicin—LRP2—Disease—SHH—pancreatic cancer	0.0017	0.0049	CbGpPWpGaD
Gentamicin—Hypertension—Gemcitabine—pancreatic cancer	0.00169	0.00258	CcSEcCtD
Gentamicin—LRP2—Disease—IAPP—pancreatic cancer	0.00168	0.00484	CbGpPWpGaD
Gentamicin—Phlebitis—Doxorubicin—pancreatic cancer	0.00167	0.00255	CcSEcCtD
Gentamicin—Convulsion—Fluorouracil—pancreatic cancer	0.00167	0.00255	CcSEcCtD
Gentamicin—Arthralgia—Gemcitabine—pancreatic cancer	0.00166	0.00255	CcSEcCtD
Gentamicin—Agranulocytosis—Docetaxel—pancreatic cancer	0.00166	0.00253	CcSEcCtD
Gentamicin—Confusional state—Irinotecan—pancreatic cancer	0.00165	0.00253	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—DTX4—pancreatic cancer	0.00164	0.00475	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GLI1—pancreatic cancer	0.00164	0.00475	CbGpPWpGaD
Gentamicin—Pruritus—Tamoxifen—pancreatic cancer	0.00164	0.00251	CcSEcCtD
Gentamicin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00164	0.0025	CcSEcCtD
Gentamicin—Pruritus—Erlotinib—pancreatic cancer	0.00163	0.00249	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.00162	0.00469	CbGpPWpGaD
Gentamicin—Purpura—Epirubicin—pancreatic cancer	0.00161	0.00247	CcSEcCtD
Gentamicin—LRP2—Disease—HSPA1B—pancreatic cancer	0.00161	0.00465	CbGpPWpGaD
Gentamicin—Vascular purpura—Doxorubicin—pancreatic cancer	0.00161	0.00246	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00161	0.00246	CcSEcCtD
Gentamicin—Thrombocytopenia—Irinotecan—pancreatic cancer	0.0016	0.00245	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NRP1—pancreatic cancer	0.0016	0.00462	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.0016	0.00462	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.0016	0.00244	CcSEcCtD
Gentamicin—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00159	0.00243	CcSEcCtD
Gentamicin—Lethargy—Epirubicin—pancreatic cancer	0.00159	0.00243	CcSEcCtD
Gentamicin—LRP2—Metabolism—GLP1R—pancreatic cancer	0.00158	0.00458	CbGpPWpGaD
Gentamicin—Confusional state—Fluorouracil—pancreatic cancer	0.00158	0.00242	CcSEcCtD
Gentamicin—Body temperature increased—Sunitinib—pancreatic cancer	0.00157	0.0024	CcSEcCtD
Gentamicin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00157	0.0024	CcSEcCtD
Gentamicin—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00156	0.00239	CcSEcCtD
Gentamicin—LRP2—Metabolism—DPYD—pancreatic cancer	0.00156	0.0045	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HEY2—pancreatic cancer	0.00154	0.00445	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00154	0.00235	CcSEcCtD
Gentamicin—Visual impairment—Docetaxel—pancreatic cancer	0.00154	0.00235	CcSEcCtD
Gentamicin—Dizziness—Tamoxifen—pancreatic cancer	0.00154	0.00235	CcSEcCtD
Gentamicin—Hypotension—Irinotecan—pancreatic cancer	0.00153	0.00234	CcSEcCtD
Gentamicin—Dizziness—Erlotinib—pancreatic cancer	0.00152	0.00232	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GAST—pancreatic cancer	0.0015	0.00434	CbGpPWpGaD
Gentamicin—Purpura—Doxorubicin—pancreatic cancer	0.00149	0.00228	CcSEcCtD
Gentamicin—Hypotension—Gemcitabine—pancreatic cancer	0.00149	0.00228	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00149	0.00227	CcSEcCtD
Gentamicin—LRP2—Metabolism—SLC2A2—pancreatic cancer	0.00148	0.00427	CbGpPWpGaD
Gentamicin—Vomiting—Tamoxifen—pancreatic cancer	0.00148	0.00226	CcSEcCtD
Gentamicin—Paraesthesia—Irinotecan—pancreatic cancer	0.00147	0.00225	CcSEcCtD
Gentamicin—Lethargy—Doxorubicin—pancreatic cancer	0.00147	0.00224	CcSEcCtD
Gentamicin—Hypotension—Fluorouracil—pancreatic cancer	0.00147	0.00224	CcSEcCtD
Gentamicin—Hypersensitivity—Sunitinib—pancreatic cancer	0.00147	0.00224	CcSEcCtD
Gentamicin—Rash—Tamoxifen—pancreatic cancer	0.00146	0.00224	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.00146	0.00423	CbGpPWpGaD
Gentamicin—Dermatitis—Tamoxifen—pancreatic cancer	0.00146	0.00224	CcSEcCtD
Gentamicin—Vomiting—Erlotinib—pancreatic cancer	0.00146	0.00223	CcSEcCtD
Gentamicin—Headache—Tamoxifen—pancreatic cancer	0.00145	0.00222	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00145	0.00222	CcSEcCtD
Gentamicin—Rash—Erlotinib—pancreatic cancer	0.00145	0.00221	CcSEcCtD
Gentamicin—Dermatitis—Erlotinib—pancreatic cancer	0.00145	0.00221	CcSEcCtD
Gentamicin—LRP2—Disease—JAG1—pancreatic cancer	0.00144	0.00416	CbGpPWpGaD
Gentamicin—Headache—Erlotinib—pancreatic cancer	0.00144	0.0022	CcSEcCtD
Gentamicin—Paraesthesia—Gemcitabine—pancreatic cancer	0.00143	0.00219	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00143	0.00219	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SCT—pancreatic cancer	0.00142	0.00412	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HEY1—pancreatic cancer	0.00142	0.00412	CbGpPWpGaD
Gentamicin—Decreased appetite—Irinotecan—pancreatic cancer	0.00142	0.00218	CcSEcCtD
Gentamicin—Hypokalaemia—Epirubicin—pancreatic cancer	0.00141	0.00216	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.00141	0.00408	CbGpPWpGaD
Gentamicin—Paraesthesia—Fluorouracil—pancreatic cancer	0.00141	0.00215	CcSEcCtD
Gentamicin—Alopecia—Docetaxel—pancreatic cancer	0.00141	0.00215	CcSEcCtD
Gentamicin—Pruritus—Sunitinib—pancreatic cancer	0.00141	0.00215	CcSEcCtD
Gentamicin—Erythema—Docetaxel—pancreatic cancer	0.00139	0.00212	CcSEcCtD
Gentamicin—Decreased appetite—Gemcitabine—pancreatic cancer	0.00139	0.00212	CcSEcCtD
Gentamicin—Nausea—Tamoxifen—pancreatic cancer	0.00138	0.00211	CcSEcCtD
Gentamicin—Muscular weakness—Epirubicin—pancreatic cancer	0.00137	0.0021	CcSEcCtD
Gentamicin—LRP2—Disease—CD44—pancreatic cancer	0.00137	0.00395	CbGpPWpGaD
Gentamicin—Nausea—Erlotinib—pancreatic cancer	0.00136	0.00209	CcSEcCtD
Gentamicin—Decreased appetite—Fluorouracil—pancreatic cancer	0.00136	0.00209	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCK—pancreatic cancer	0.00136	0.00393	CbGpPWpGaD
Gentamicin—LRP2—Disease—HSPA1A—pancreatic cancer	0.00136	0.00392	CbGpPWpGaD
Gentamicin—Feeling abnormal—Irinotecan—pancreatic cancer	0.00135	0.00206	CcSEcCtD
Gentamicin—Eosinophilia—Epirubicin—pancreatic cancer	0.00133	0.00203	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CNR2—pancreatic cancer	0.00132	0.00383	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GLP1R—pancreatic cancer	0.00132	0.00383	CbGpPWpGaD
Gentamicin—Dizziness—Sunitinib—pancreatic cancer	0.00132	0.00201	CcSEcCtD
Gentamicin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00131	0.00201	CcSEcCtD
Gentamicin—Hypokalaemia—Doxorubicin—pancreatic cancer	0.00131	0.002	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.0013	0.00377	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCKAR—pancreatic cancer	0.0013	0.00377	CbGpPWpGaD
Gentamicin—Body temperature increased—Irinotecan—pancreatic cancer	0.00129	0.00198	CcSEcCtD
Gentamicin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00129	0.00198	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.00129	0.00372	CbGpPWpGaD
Gentamicin—Anaemia—Docetaxel—pancreatic cancer	0.00128	0.00196	CcSEcCtD
Gentamicin—Muscular weakness—Doxorubicin—pancreatic cancer	0.00127	0.00194	CcSEcCtD
Gentamicin—Vomiting—Sunitinib—pancreatic cancer	0.00126	0.00193	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—JAG2—pancreatic cancer	0.00126	0.00365	CbGpPWpGaD
Gentamicin—Body temperature increased—Gemcitabine—pancreatic cancer	0.00126	0.00193	CcSEcCtD
Gentamicin—Rash—Sunitinib—pancreatic cancer	0.00125	0.00192	CcSEcCtD
Gentamicin—Dermatitis—Sunitinib—pancreatic cancer	0.00125	0.00192	CcSEcCtD
Gentamicin—Urticaria—Fluorouracil—pancreatic cancer	0.00125	0.00191	CcSEcCtD
Gentamicin—Headache—Sunitinib—pancreatic cancer	0.00125	0.00191	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—MEN1—pancreatic cancer	0.00125	0.0036	CbGpPWpGaD
Gentamicin—Leukopenia—Docetaxel—pancreatic cancer	0.00124	0.0019	CcSEcCtD
Gentamicin—Body temperature increased—Fluorouracil—pancreatic cancer	0.00124	0.0019	CcSEcCtD
Gentamicin—Eosinophilia—Doxorubicin—pancreatic cancer	0.00123	0.00188	CcSEcCtD
Gentamicin—Weight decreased—Epirubicin—pancreatic cancer	0.00122	0.00186	CcSEcCtD
Gentamicin—Hypersensitivity—Irinotecan—pancreatic cancer	0.00121	0.00185	CcSEcCtD
Gentamicin—Convulsion—Docetaxel—pancreatic cancer	0.0012	0.00184	CcSEcCtD
Gentamicin—Hypertension—Docetaxel—pancreatic cancer	0.0012	0.00183	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SHH—pancreatic cancer	0.00119	0.00343	CbGpPWpGaD
Gentamicin—Arthralgia—Docetaxel—pancreatic cancer	0.00118	0.00181	CcSEcCtD
Gentamicin—Nausea—Sunitinib—pancreatic cancer	0.00118	0.00181	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NOTCH4—pancreatic cancer	0.00118	0.00341	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00117	0.0018	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—IAPP—pancreatic cancer	0.00117	0.00339	CbGpPWpGaD
Gentamicin—Stomatitis—Epirubicin—pancreatic cancer	0.00117	0.00179	CcSEcCtD
Gentamicin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00116	0.00177	CcSEcCtD
Gentamicin—LRP2—Metabolism—CD44—pancreatic cancer	0.00115	0.00331	CbGpPWpGaD
Gentamicin—Confusional state—Docetaxel—pancreatic cancer	0.00114	0.00175	CcSEcCtD
Gentamicin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00113	0.00173	CcSEcCtD
Gentamicin—Pruritus—Gemcitabine—pancreatic cancer	0.00113	0.00173	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PTHLH—pancreatic cancer	0.00113	0.00325	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTCH1—pancreatic cancer	0.00113	0.00325	CbGpPWpGaD
Gentamicin—Weight decreased—Doxorubicin—pancreatic cancer	0.00112	0.00172	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.00112	0.00324	CbGpPWpGaD
Gentamicin—Agranulocytosis—Epirubicin—pancreatic cancer	0.00112	0.00171	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.00111	0.00321	CbGpPWpGaD
Gentamicin—Pruritus—Fluorouracil—pancreatic cancer	0.00111	0.0017	CcSEcCtD
Gentamicin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00111	0.0017	CcSEcCtD
Gentamicin—LRP2—Metabolism—GCG—pancreatic cancer	0.0011	0.00317	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.00109	0.00166	CcSEcCtD
Gentamicin—Dizziness—Irinotecan—pancreatic cancer	0.00108	0.00166	CcSEcCtD
Gentamicin—Stomatitis—Doxorubicin—pancreatic cancer	0.00108	0.00165	CcSEcCtD
Gentamicin—LRP2—Disease—SMAD4—pancreatic cancer	0.00108	0.00312	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00107	0.00164	CcSEcCtD
Gentamicin—Hypotension—Docetaxel—pancreatic cancer	0.00106	0.00162	CcSEcCtD
Gentamicin—LRP2—Disease—HES1—pancreatic cancer	0.00105	0.00305	CbGpPWpGaD
Gentamicin—Vomiting—Irinotecan—pancreatic cancer	0.00104	0.00159	CcSEcCtD
Gentamicin—Dizziness—Fluorouracil—pancreatic cancer	0.00104	0.00159	CcSEcCtD
Gentamicin—Visual impairment—Epirubicin—pancreatic cancer	0.00104	0.00158	CcSEcCtD
Gentamicin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00103	0.00158	CcSEcCtD
Gentamicin—Rash—Irinotecan—pancreatic cancer	0.00103	0.00158	CcSEcCtD
Gentamicin—LRP2—Metabolism—STK11—pancreatic cancer	0.00103	0.00298	CbGpPWpGaD
Gentamicin—Dermatitis—Irinotecan—pancreatic cancer	0.00103	0.00158	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00103	0.00158	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SST—pancreatic cancer	0.00103	0.00298	CbGpPWpGaD
Gentamicin—Headache—Irinotecan—pancreatic cancer	0.00103	0.00157	CcSEcCtD
Gentamicin—Paraesthesia—Docetaxel—pancreatic cancer	0.00102	0.00155	CcSEcCtD
Gentamicin—Vomiting—Gemcitabine—pancreatic cancer	0.00101	0.00155	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—JAG1—pancreatic cancer	0.00101	0.00291	CbGpPWpGaD
Gentamicin—Rash—Gemcitabine—pancreatic cancer	0.00101	0.00154	CcSEcCtD
Gentamicin—Dermatitis—Gemcitabine—pancreatic cancer	0.00101	0.00154	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NOTCH3—pancreatic cancer	0.001	0.0029	CbGpPWpGaD
Gentamicin—Tinnitus—Epirubicin—pancreatic cancer	0.001	0.00153	CcSEcCtD
Gentamicin—Headache—Gemcitabine—pancreatic cancer	0.001	0.00153	CcSEcCtD
Gentamicin—Vomiting—Fluorouracil—pancreatic cancer	0.000998	0.00153	CcSEcCtD
Gentamicin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00099	0.00151	CcSEcCtD
Gentamicin—Rash—Fluorouracil—pancreatic cancer	0.000989	0.00151	CcSEcCtD
Gentamicin—Dermatitis—Fluorouracil—pancreatic cancer	0.000988	0.00151	CcSEcCtD
Gentamicin—Decreased appetite—Docetaxel—pancreatic cancer	0.000984	0.00151	CcSEcCtD
Gentamicin—Headache—Fluorouracil—pancreatic cancer	0.000983	0.0015	CcSEcCtD
Gentamicin—Nausea—Irinotecan—pancreatic cancer	0.000973	0.00149	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.000969	0.0028	CbGpPWpGaD
Gentamicin—Visual impairment—Doxorubicin—pancreatic cancer	0.000959	0.00147	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CNR1—pancreatic cancer	0.000951	0.00275	CbGpPWpGaD
Gentamicin—Alopecia—Epirubicin—pancreatic cancer	0.00095	0.00145	CcSEcCtD
Gentamicin—Nausea—Gemcitabine—pancreatic cancer	0.000948	0.00145	CcSEcCtD
Gentamicin—Erythema—Epirubicin—pancreatic cancer	0.000936	0.00143	CcSEcCtD
Gentamicin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000933	0.00143	CcSEcCtD
Gentamicin—Nausea—Fluorouracil—pancreatic cancer	0.000932	0.00143	CcSEcCtD
Gentamicin—Tinnitus—Doxorubicin—pancreatic cancer	0.000927	0.00142	CcSEcCtD
Gentamicin—LRP2—Disease—TERT—pancreatic cancer	0.000924	0.00267	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GCG—pancreatic cancer	0.000918	0.00265	CbGpPWpGaD
Gentamicin—Body temperature increased—Docetaxel—pancreatic cancer	0.000895	0.00137	CcSEcCtD
Gentamicin—LRP2—Metabolism—TYMS—pancreatic cancer	0.000888	0.00257	CbGpPWpGaD
Gentamicin—LRP2—Disease—HIF1A—pancreatic cancer	0.000883	0.00255	CbGpPWpGaD
Gentamicin—LRP2—Disease—TSC2—pancreatic cancer	0.000881	0.00255	CbGpPWpGaD
Gentamicin—Alopecia—Doxorubicin—pancreatic cancer	0.000879	0.00134	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—AGTR1—pancreatic cancer	0.000876	0.00253	CbGpPWpGaD
Gentamicin—Erythema—Doxorubicin—pancreatic cancer	0.000866	0.00132	CcSEcCtD
Gentamicin—Anaemia—Epirubicin—pancreatic cancer	0.000865	0.00132	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—STK11—pancreatic cancer	0.000863	0.00249	CbGpPWpGaD
Gentamicin—LRP2—Disease—APOE—pancreatic cancer	0.000862	0.00249	CbGpPWpGaD
Gentamicin—Vertigo—Epirubicin—pancreatic cancer	0.000841	0.00129	CcSEcCtD
Gentamicin—Leukopenia—Epirubicin—pancreatic cancer	0.000838	0.00128	CcSEcCtD
Gentamicin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000834	0.00128	CcSEcCtD
Gentamicin—Convulsion—Epirubicin—pancreatic cancer	0.000811	0.00124	CcSEcCtD
Gentamicin—Hypertension—Epirubicin—pancreatic cancer	0.000808	0.00124	CcSEcCtD
Gentamicin—Pruritus—Docetaxel—pancreatic cancer	0.000801	0.00123	CcSEcCtD
Gentamicin—Anaemia—Doxorubicin—pancreatic cancer	0.0008	0.00122	CcSEcCtD
Gentamicin—Arthralgia—Epirubicin—pancreatic cancer	0.000797	0.00122	CcSEcCtD
Gentamicin—LRP2—Disease—NOTCH1—pancreatic cancer	0.000796	0.0023	CbGpPWpGaD
Gentamicin—Vertigo—Doxorubicin—pancreatic cancer	0.000778	0.00119	CcSEcCtD
Gentamicin—Leukopenia—Doxorubicin—pancreatic cancer	0.000775	0.00119	CcSEcCtD
Gentamicin—Confusional state—Epirubicin—pancreatic cancer	0.00077	0.00118	CcSEcCtD
Gentamicin—LRP2—Disease—EGF—pancreatic cancer	0.000769	0.00222	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000764	0.00117	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SMAD4—pancreatic cancer	0.000756	0.00218	CbGpPWpGaD
Gentamicin—Convulsion—Doxorubicin—pancreatic cancer	0.00075	0.00115	CcSEcCtD
Gentamicin—Dizziness—Docetaxel—pancreatic cancer	0.000749	0.00115	CcSEcCtD
Gentamicin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000748	0.00114	CcSEcCtD
Gentamicin—Hypertension—Doxorubicin—pancreatic cancer	0.000748	0.00114	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HES1—pancreatic cancer	0.000738	0.00213	CbGpPWpGaD
Gentamicin—Arthralgia—Doxorubicin—pancreatic cancer	0.000737	0.00113	CcSEcCtD
Gentamicin—LRP2—Metabolism—APOE—pancreatic cancer	0.000722	0.00209	CbGpPWpGaD
Gentamicin—Vomiting—Docetaxel—pancreatic cancer	0.00072	0.0011	CcSEcCtD
Gentamicin—Rash—Docetaxel—pancreatic cancer	0.000714	0.00109	CcSEcCtD
Gentamicin—Hypotension—Epirubicin—pancreatic cancer	0.000714	0.00109	CcSEcCtD
Gentamicin—Dermatitis—Docetaxel—pancreatic cancer	0.000713	0.00109	CcSEcCtD
Gentamicin—Confusional state—Doxorubicin—pancreatic cancer	0.000713	0.00109	CcSEcCtD
Gentamicin—Headache—Docetaxel—pancreatic cancer	0.000709	0.00108	CcSEcCtD
Gentamicin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000707	0.00108	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000696	0.00106	CcSEcCtD
Gentamicin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000692	0.00106	CcSEcCtD
Gentamicin—Paraesthesia—Epirubicin—pancreatic cancer	0.000686	0.00105	CcSEcCtD
Gentamicin—LRP2—Disease—PIK3CD—pancreatic cancer	0.000684	0.00198	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	0.000684	0.00198	CbGpPWpGaD
Gentamicin—Nausea—Docetaxel—pancreatic cancer	0.000673	0.00103	CcSEcCtD
Gentamicin—Decreased appetite—Epirubicin—pancreatic cancer	0.000664	0.00102	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000663	0.00192	CbGpPWpGaD
Gentamicin—Hypotension—Doxorubicin—pancreatic cancer	0.00066	0.00101	CcSEcCtD
Gentamicin—LRP2—Metabolism—PIK3CG—pancreatic cancer	0.000652	0.00188	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TERT—pancreatic cancer	0.000647	0.00187	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000644	0.000985	CcSEcCtD
Gentamicin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000635	0.00097	CcSEcCtD
Gentamicin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000629	0.000962	CcSEcCtD
Gentamicin—LRP2—Metabolism—PPARG—pancreatic cancer	0.000629	0.00182	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HIF1A—pancreatic cancer	0.000619	0.00179	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TSC2—pancreatic cancer	0.000617	0.00178	CbGpPWpGaD
Gentamicin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000614	0.000939	CcSEcCtD
Gentamicin—Urticaria—Epirubicin—pancreatic cancer	0.000607	0.000928	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—APOE—pancreatic cancer	0.000604	0.00174	CbGpPWpGaD
Gentamicin—Body temperature increased—Epirubicin—pancreatic cancer	0.000604	0.000923	CcSEcCtD
Gentamicin—LRP2—Disease—PIK3CB—pancreatic cancer	0.000596	0.00172	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KDR—pancreatic cancer	0.000592	0.00171	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTGS2—pancreatic cancer	0.000591	0.00171	CbGpPWpGaD
Gentamicin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000582	0.000891	CcSEcCtD
Gentamicin—LRP2—Metabolism—PIK3CD—pancreatic cancer	0.000573	0.00166	CbGpPWpGaD
Gentamicin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000563	0.000861	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000563	0.00163	CbGpPWpGaD
Gentamicin—Urticaria—Doxorubicin—pancreatic cancer	0.000561	0.000859	CcSEcCtD
Gentamicin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000559	0.000854	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NOTCH1—pancreatic cancer	0.000557	0.00161	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000545	0.00157	CbGpPWpGaD
Gentamicin—Pruritus—Epirubicin—pancreatic cancer	0.00054	0.000826	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—EGF—pancreatic cancer	0.000539	0.00156	CbGpPWpGaD
Gentamicin—LRP2—Disease—CTNNB1—pancreatic cancer	0.000529	0.00153	CbGpPWpGaD
Gentamicin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000521	0.000796	CcSEcCtD
Gentamicin—LRP2—Disease—PTEN—pancreatic cancer	0.000515	0.00149	CbGpPWpGaD
Gentamicin—Dizziness—Epirubicin—pancreatic cancer	0.000505	0.000772	CcSEcCtD
Gentamicin—Pruritus—Doxorubicin—pancreatic cancer	0.0005	0.000765	CcSEcCtD
Gentamicin—LRP2—Metabolism—PIK3CB—pancreatic cancer	0.000499	0.00144	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTGS2—pancreatic cancer	0.000495	0.00143	CbGpPWpGaD
Gentamicin—Vomiting—Epirubicin—pancreatic cancer	0.000486	0.000743	CcSEcCtD
Gentamicin—Rash—Epirubicin—pancreatic cancer	0.000482	0.000736	CcSEcCtD
Gentamicin—Dermatitis—Epirubicin—pancreatic cancer	0.000481	0.000736	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PIK3CD—pancreatic cancer	0.000479	0.00138	CbGpPWpGaD
Gentamicin—Headache—Epirubicin—pancreatic cancer	0.000478	0.000732	CcSEcCtD
Gentamicin—LRP2—Disease—SRC—pancreatic cancer	0.000478	0.00138	CbGpPWpGaD
Gentamicin—Dizziness—Doxorubicin—pancreatic cancer	0.000467	0.000715	CcSEcCtD
Gentamicin—LRP2—Disease—STAT3—pancreatic cancer	0.000461	0.00133	CbGpPWpGaD
Gentamicin—LRP2—Disease—NRAS—pancreatic cancer	0.00046	0.00133	CbGpPWpGaD
Gentamicin—Nausea—Epirubicin—pancreatic cancer	0.000454	0.000694	CcSEcCtD
Gentamicin—Vomiting—Doxorubicin—pancreatic cancer	0.000449	0.000687	CcSEcCtD
Gentamicin—Rash—Doxorubicin—pancreatic cancer	0.000446	0.000681	CcSEcCtD
Gentamicin—Dermatitis—Doxorubicin—pancreatic cancer	0.000445	0.000681	CcSEcCtD
Gentamicin—Headache—Doxorubicin—pancreatic cancer	0.000443	0.000677	CcSEcCtD
Gentamicin—LRP2—Metabolism—PTEN—pancreatic cancer	0.000432	0.00125	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYC—pancreatic cancer	0.000428	0.00124	CbGpPWpGaD
Gentamicin—LRP2—Disease—TGFB1—pancreatic cancer	0.000427	0.00123	CbGpPWpGaD
Gentamicin—Nausea—Doxorubicin—pancreatic cancer	0.00042	0.000642	CcSEcCtD
Gentamicin—LRP2—Disease—EGFR—pancreatic cancer	0.000419	0.00121	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CB—pancreatic cancer	0.000418	0.00121	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL8—pancreatic cancer	0.000401	0.00116	CbGpPWpGaD
Gentamicin—LRP2—Disease—KRAS—pancreatic cancer	0.000396	0.00114	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CASP3—pancreatic cancer	0.000384	0.00111	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCND1—pancreatic cancer	0.000374	0.00108	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CTNNB1—pancreatic cancer	0.00037	0.00107	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CA—pancreatic cancer	0.000363	0.00105	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—pancreatic cancer	0.000363	0.00105	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTEN—pancreatic cancer	0.000361	0.00104	CbGpPWpGaD
Gentamicin—LRP2—Disease—HRAS—pancreatic cancer	0.000336	0.000972	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SRC—pancreatic cancer	0.000335	0.000967	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—pancreatic cancer	0.000326	0.000942	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT3—pancreatic cancer	0.000323	0.000932	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NRAS—pancreatic cancer	0.000322	0.00093	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CA—pancreatic cancer	0.000304	0.00088	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MYC—pancreatic cancer	0.0003	0.000866	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TGFB1—pancreatic cancer	0.000299	0.000864	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT1—pancreatic cancer	0.000297	0.000858	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGFR—pancreatic cancer	0.000293	0.000847	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KRAS—pancreatic cancer	0.000277	0.000801	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CA—pancreatic cancer	0.000255	0.000736	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKT1—pancreatic cancer	0.000249	0.000719	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—pancreatic cancer	0.000246	0.000712	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HRAS—pancreatic cancer	0.000236	0.000681	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT1—pancreatic cancer	0.000208	0.000601	CbGpPWpGaD
